Xcell Therapeutics Inc.
Develops serum-free media & automated systems for cell therapy & regenerative medicine.
373110 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 영동대로 333 동원빌딩 6층, 강남구
- Website:
- https://www.xcell.co.kr/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Xcell Therapeutics Inc., founded in 2015, is a biotechnology company specializing in advanced cell culture solutions for the regenerative medicine and cell therapy industries. The company develops and manufactures serum-free, chemically defined media, with its flagship product line, CellCor™, designed to provide an optimal environment for Mesenchymal Stem Cell (MSC) culture. CellCor™ aims to deliver higher yields, greater efficiency, and cost-effectiveness for researchers and therapy developers. Committed to ethical and eco-friendly practices, its serum-free products eliminate the need for bovine serum. Xcell Therapeutics is also expanding its technological portfolio to include automated mass cell culture systems and exosome isolation and purification devices, such as its EXODUS system, to support the broader biotechnology sector.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-19 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등거래계획보고서
|
Korean | 43.3 KB | ||
| 2025-09-16 00:00 |
Prospectus
투자설명서
|
Korean | 2.2 MB | ||
| 2025-09-15 00:00 |
Registration Form
[기재정정]증권신고서(지분증권) (2025.11)
|
Korean | 2.6 MB | ||
| 2025-09-12 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.9 KB | ||
| 2025-09-01 00:00 |
Registration Form
[기재정정]증권신고서(지분증권) (2025.11)
|
Korean | 2.8 MB | ||
| 2025-08-21 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 7.2 KB | ||
| 2025-08-18 00:00 |
Registration Form
증권신고서(지분증권) (2025.11)
|
Korean | 2.0 MB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.2 MB | ||
| 2025-08-14 00:00 |
Share Issue/Capital Change
주요사항보고서(유상증자결정)
|
Korean | 35.8 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.2 MB | ||
| 2025-03-28 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 19.2 KB | ||
| 2025-03-28 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 14.7 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 26.5 KB | ||
| 2025-03-20 00:00 |
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
|
Korean | 431.9 KB |
Automate Your Workflow. Get a real-time feed of all Xcell Therapeutics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Xcell Therapeutics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
